Crossmark

In silico and in vitro investigations reveal pan-PPAR agonist activity and anti-NAFLD efficacy of polydatin by modulating hepatic lipid-energy metabolism

Crossref DOI link: https://doi.org/10.1038/s41598-025-12357-0

Published Online: 2025-07-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mandal, Sumit Kumar

Muzaffar-Ur-Rehman, Mohammed

Puri, Sonakshi

Sharma, Pankaj Kumar

Murugesan, Sankaranarayanan

Deepa, P. R.
Funding

Funding for this research was provided by:

Birla Institute of Technology and Science, Pilani
License Information

Text and Data Mining valid from 2025-07-24

Version of Record valid from 2025-07-24
More Information

Article History

Received: 9 March 2025

Accepted: 16 July 2025

First Online: 24 July 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below